Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE:300158) agreed to acquire additional 53.985% stake in Guangdong Longchuangji Pharmaceutical Co., Ltd. from Guangdong Qiangji Pharmaceutical Co., Ltd. on January 19, 2024. The deal has been unanimously approved by board of directors of Shanxi Zhendong Pharmaceutical Co.,Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.04 CNY | -0.98% | -2.65% | -40.15% |
20/05 | Shanxi Zhendong Pharmaceutical Co.,Ltd Approves Board Appointments | CI |
06/05 | Tranche Update on Shanxi Zhendong Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on February 6, 2024. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.15% | 572M | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- 300158 Stock
- News Shanxi Zhendong Pharmaceutical Co.,Ltd
- Shanxi Zhendong Pharmaceutical Co.,Ltd agreed to acquire additional 53.985% stake in Guangdong Longchuangji Pharmaceutical Co., Ltd. from Guangdong Qiangji Pharmaceutical Co., Ltd.